Related Experiment Video
Updated: May 16, 2026

08:41
Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Automated Computed Tomography-based Liver Steatosis Risk Stratification of Deceased Organ Donors Using Real-world
Dominic Amara1,2,3, Andrew Melehy1,2, Jeffrey Feng2
1Department of Surgery, University of California Los Angeles, Los Angeles, CA.
Transplantation
|May 14, 2026
Summary
Automated analysis of computed tomography (CT) scans accurately predicts macrovesicular steatosis in liver transplant donors. This approach, using a 2-step radiomic model, can streamline donor evaluation and improve outcomes.
Area of Science:
- Radiology
- Organ Transplantation
- Medical Imaging Analysis
Background:
- Macrovesicular steatosis in liver donors increases transplant risks.
- Prerecovery computed tomography (CT) assessment is variable and requires expertise.
- Automating CT-based steatosis evaluation can improve efficiency.
Purpose of the Study:
- To develop and validate automated methods for assessing macrovesicular steatosis in liver donor CT scans.
- To compare the performance of different predictive models, including clinical features, univariable metrics, radiomics, and deep learning.
Main Methods:
- Analysis of 147 liver donor CT scans with biopsy reports.
- Automatic segmentation of liver and spleen.
- Development of predictive models: clinical features, univariable metrics (liver attenuation, liver-to-spleen ratio, liver-spleen difference), radiomics, a 2-step radiomic approach, and a 3D convolutional neural network.
- Performance evaluation using area under the receiver operating characteristic (AUROC) with repeated cross-validation.
Main Results:
- The 2-step automated approach achieved a high AUROC of 0.87 (IQR, 0.81-0.92).
- Univariable models showed strong performance: liver attenuation (AUROC 0.81), liver-to-spleen ratio (AUROC 0.84), and liver-spleen difference (AUROC 0.83).
- The 2-step model significantly outperformed the clinical-only model (AUROC 0.65).
Conclusions:
- An automated 2-step radiomic model effectively predicts macrovesicular steatosis in liver donors.
- This automated method can support clinical decision-making in the donor-offer process.
- Streamlining donor evaluation can expedite the process and potentially improve transplant outcomes.

